AI assistant
Q32 Bio Inc. — Director's Dealing 2024
Oct 17, 2024
34891_dirs_2024-10-16_d9d8e8f1-6a09-4b8c-b498-ea54bf9be8ef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Q32 Bio Inc. (QTTB)
CIK: 0001661998
Period of Report: 2024-10-11
Reporting Person: Violette Shelia M. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-10-11 | Common Stock | M | 4574 | $3.12 | Acquired | 17874 | Direct |
| 2024-10-15 | Common Stock | M | 6000 | $7.29 | Acquired | 23874 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-10-11 | Stock Option (Right to Buy) | $3.12 | M | 213 | Disposed | 2028-12-06 | Common Stock (213) | Direct |
| 2024-10-11 | Stock Option (Right to Buy) | $3.12 | M | 4361 | Disposed | 2028-12-06 | Common Stock (4361) | Direct |
| 2024-10-15 | Stock Option (Right to Buy) | $7.29 | M | 6000 | Disposed | 2030-12-01 | Common Stock (6000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 36277 | Indirect |
Footnotes
F1: Shares held by Violette Holdings LLC ("Violette Holdings"). The Reporting Person is a manager of Violette Holdings and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose.
F2: The shares underlying this option are fully vested and exercisable as of the date hereof.
F3: The shares underlying this option vest and become exercisable in sixteen (16) equal quarterly installments following December 2, 2020, subject to the Reporting Person's continued service on each such vesting date.